Table 1

Demographic features of 40 patients with CCPD

Basic demographicsN=40
 Sex ratio (male/female)11:29
 Age at onset (years, mean±SD)31.7±14.1
 Age at examination (years, mean±SD)36.5±14.6
 Follow-up period (months, mean±SD)*93.0±91.8
 Disease duration (months, mean±SD)*137.9±124.8
Mode of onsetn/N (%)
 Acute6/31 (19.4)
 Subacute14/31 (45.2)
 Chronic11/31 (35.5)
Clinical coursen/N (%)
 Monophasic10/38 (26.3)
 Relapse–remitting20/38 (52.6)
 Chronic progressive8/38 (21.1)
Initial symptomsn/N (%)
 Related to CNS involvement15/38 (39.5)
 Related to PNS involvement15/38 (39.5)
 Simultaneous or sequential8/38 (21.0)
Fulfilment of MS or CIDP criterian/N (%)
 McDonald criteria for MS27/40 (67.5)
 EFNS/PNS definite criteria for CIDP35/40 (87.5)
Symptoms and signs during the entire coursen/N (%)
 Seizure†3/40 (7.5)
 Mental disturbance†5/40 (12.5)
 Visual disturbance†19/40 (47.5)
  Right1/19 (5.3)
  Left8/19 (42.1)
  Bilateral10/19 (52.6)
 Cranial nerve involvement (other than the optic nerves)17/39 (43.6)
 Motor weakness‡37/40 (92.5)
  Hemiplegia†10/36 (27.8)
  Paraplegia†6/36 (16.7)
  Weakness of 4 extremities§24/36 (66.7)
 Muscle atrophy§11/40 (27.5)
 Respiratory disturbance3/40 (7.5)
 Gait disturbance31/39 (79.5)
 Cerebellar ataxia†10/38 (26.3)
 Sensory disturbance37/39 (94.9)
  Half-body involvement†5/37 (13.5)
  Sensory level†14/37 (37.8)
  Glove and stocking type§22/37 (59.4)
  Other types3/37 (8.1)
 Deep tendon reflexes
  Hyporeflexia§26/40 (65.0)
  Normal1/40 (2.5)
  Hyper-reflexia†9/40 (22.5)
  Both hyporeflexia and hyper-reflexia4/40 (10.0)
 Pathological reflexes†18/40 (45.0)
 Sphincter disturbance†18/38 (47.4)
  • *Two patients’ data were missing.

  • †Symptoms derived from CNS involvement.

  • ‡Detail of motor weakness in one patient was unknown.

  • §Symptoms derived from PNS involvement.

  • CCPD, combined central and peripheral demyelination; CIDP, chronic inflammatory demyelinating polyradiculoneuropathy; CNS, central nervous system; n, number of involved cases; N, number of cases collated; MS, multiple sclerosis; PNS, peripheral nervous system.